CRT 2026

Q&A with the Panel

Moderator(s)

• 

  Marc Cohen, MD

  Chair of Medicine
  Newark Beth Israel Med Ctr
  Philadelphia, Pennsylvania, United States

  Disclosure(s): BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Grant/Research Support (Ongoing)
• 

  C. Michael Gibson, MD

  Professor of Medicine
  Beth Israel Deaconess Medical Center
  Boston, Massachusetts, United States

  Disclosure information not submitted.
• 

  Neal S. Kleiman, MD, FACC, MSCAI

  Medical Director, Cardiac Catheterization Laboratories
  Houston Methodist DeBakey Heart and Vascular Center
  Houston, Texas, United States

  Disclosure information not submitted.

Panel Discussant(s)

• 

  Sukhdeep S. Bhogal, MD

  Interventional Cardiologist
  Sovah Health
  Roanoke, Virginia, United States

  Disclosure(s): No financial relationships to disclose
• 

  Michael J. Lipinski, MD, PhD

  Interventional Cardiologist
  Lee Health Heart Institute
  Charlottesville, Virginia, United States

  Disclosure(s): Pfizer: Stock-publicly held company (excluding mutual/index funds) (Ongoing); Sanofi/Genzyme: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); United Healthcare: Stock-publicly held company (excluding mutual/index funds) (Ongoing)
• 

  Robert S. Rosenson, MD

  Director of Metabolism and Lipids
  Mount Sinai Health System
  New York, New York, United States

  Disclosure information not submitted.
• JR

  Jennifer Rymer, MD

  Interventional cardiologist
  Duke, North Carolina, United States

  Disclosure information not submitted.
• 

  Tiziana Claudia Aranzulla, MD, MSc

  Interventional cardiology
  A.O. Ordine Mauriziano di Torino
  Turin, Italy

  Disclosure(s): No financial relationships to disclose